Amgen Highlights The Latest EVENITY™ (Romosozumab) And Prolia® (Denosumab) Research At The American Society For Bone And Mineral Research Annual Meeting
Go back to Amgen Highlights The Latest EVENITY™ (Romosozumab) And Prolia® (Denosumab) Research At The American Society For Bone And Mineral Research Annual Meeting| Amgen Inc (NASDAQ: AMGN) | Delayed: 393.17 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $393.17 | 52 Week High | $176.85 | |||
| Open | $393.17 | 52 Week Low | $133.64 | |||
| Day High | $393.17 | P/E | 59.21 | |||
| Day Low | $393.17 | EPS | $6.64 | |||
| Volume | 4,693 | |||||

